Sfoglia per AUTORE
TISEO M
Collezione AOU Novara

  

Items : 8

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Russo A; Russano M; Tiseo M; Porzio G; Ficorella C; Addeo A; Friedlaender A; Banna GL; Passiglia F; Spinelli GP; Metro G; Migliorino MR; Zoratto F; Ricciardi S; Mansueto G; Pecci F; Di Marino P; Gori S; De Tursi M; Tuzi A; Della Gravara L; Rastelli F; Macerelli M; Gelibter A; Chiari R; Marchetti P; Antonuzzo L; Mazzoni F; Genova C; et alii...

Host immune-inflammatory markers to unravel the heterogeneous outcome and assessment of patients with PD-L1 ?50% metastatic non-small cell lung cancer and poor performance status receiving first-line immunotherapy. in Thoracic cancer / Thorac Cancer. 2022 Feb;13(3):483-488. doi: 10.1111/1759-7714.14256. Epub 2021 Dec 22.

2022
ASL Città di Torino
AOU Novara

Cortellini A; Addeo A; Pinato DJ; Porzio G; Ficorella C; Pensieri MV; Friedlaender A; Metro G; De Toma A; Cappuzzo F; Bertolini F; Rijavec E; Citarella F; Cantini L; Mansueto G; Gori S; Macerelli M; Chiari R; Rastelli F; Gelibter A; Mazzoni F; Catino A; Genova C; Morabito A; Grossi F; Berardi R; Bria E; Giusti R; Baldessari C; et alii...

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Novara

Russo A; Adamo V; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Ricciardi S; Landi L; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Filetti M; Zoratto F; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Gelibter A; Targato G; Signorelli D; De Toma A; Mazzoni F; et alii...

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cannita K; Porzio G; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Tuzi A; Bisonni R; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Mazzoni F; Russano M; Citarella F; Filetti M; Zoratto F; Mansueto G; et alii...

Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Feb;140:71-79. doi: 10.1016/j.lungcan.2019.12.006. Epub 2019 Dec 16.

2020
AOU San Luigi di Orbassano
ASL Città di Torino
ASL Torino 4
AO Alessandria
AOU Novara

Novello S; Rossi A; Ferrari S; Zullo A; Carta A; Vattemi E; Pagano M; Gelibter A; Martelli O; Pino MS; Cecere F; Berardi R; Migliorino MR; Tonini G; Galetta D; Sergi C; Nonnis D; Verderame F; Del Conte A; Scotti V; Borra G; Piovano PL; Ceresoli GL; Finocchiaro G; Romano GD; Cortinovis D; Vitiello F; Tiseo M; Barbieri F; et alii...

Listening understanding and acting (lung): focus on communicational issue in thoracic oncology. in Translational cancer research / Transl Cancer Res. 2019 Jan;8(Suppl 1):S16-S22. doi: 10.21037/tcr.2018.12.32.

2019
AOU San Luigi di Orbassano
AOU Novara

Romano G; Roca E; Morabito A; Montrone M; Minotti V; Migliorino MR; Melotti B; Mazzanti P; Martelli O; Malorgio F; Mancuso G; Landi L; Irtelli L; Gregorc V; Gilli M; Franchina T; Del Conte A; D'Argento E; Cusmai A; Danesi R; Costanzo R; Cortinovis D; Carta A; Bulotta A; Buffoni L; Borra G; Bettini A; Bianco R; Barbieri V; et alii...

Crizotinib in MET-Deregulated or ROS1-Rearranged Pretreated Non-Small Cell Lung Cancer (METROS): A Phase II, Prospective, Multicenter, Two-Arms Trial. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2019 Dec 15;25(24):7312-7319. doi: 10.1158/1078-0432.CCR-19-0994. Epub 2019 Aug 15.

2019
AOU Novara

Landi L; Chiari R; Tiseo M; D'Incà F; Dazzi C; Chella A; Delmonte A; Bonanno L; Giannarelli D; Cortinovis DL; de Marinis F; Borra G; Morabito A; Gridelli C; Galetta D; Barbieri F; Grossi F; Capelletto E; Minuti G; Mazzoni F; Verusio C; Bria E; Alì G; Bruno R; Proietti A; Fontanini G; Crinò L; Cappuzzo F;

Classification of different patterns of pulmonary adenocarcinomas. in Expert review of respiratory medicine / Expert Rev Respir Med. 2015 Oct;9(5):571-86. doi: 10.1586/17476348.2015.1083428. Epub 2015 Aug 27.

2015
AOU Novara

Truini A; Santos Pereira P; Cavazza A; Spagnolo P; Nosseir S; Longo L; Jukna A; Lococo F; Vincenzi G; Bogina G; Tiseo M; Rossi G;